Philip Ball

Executive Officer, Director at Tolerance Bio.

Raised on Tolerance Bio filings

$15.1M

across 1 Form D filing

Form D filings: 1
Teammates: 5
Last filing: Jun 18, 2026

Company

Biotech · Philadelphia, PA

Stem cell-derived thymus therapies for immune tolerance

Stem cell-derived thymus therapies for immune tolerance

Investors: 13
Founded: 2023

Investors: 13
Sector: Biotech
Founded: 2023
HQ: Philadelphia, PA

Tolerance Bio filings

Tolerance Bio Form D filings
Filed	Security	Sold of offered	Filing
Jun 18, 2026	Equity	$15.1M/ no target	Form D

EquityFiled Jun 18, 2026Form D
$15.1M/ no target

Works with

Also named on Tolerance Bio filings

Francisco LeonChief Executive Officer, Form D signerForm D signer Pablo CironiDirector Damia Tormo CarullaDirector Justin VogelExecutive Officer, Director Robert GoldsteinDirector